市場調査レポート

商品コード

1315740

非侵襲的出生前検査市場：製品、方法、用途、エンドユーザー別-2023-2030年の世界予測

Non-invasive Prenatal Testing Market by Product, Method, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 749,867円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 907,767円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,065,667円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,381,467円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

非侵襲的出生前検査の世界市場は大きく成長すると予測され、2023年には64億8,903万米ドルが予測され、CAGRは13.79%、2030年には160億5,439万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の非侵襲的出生前検査市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.非侵襲的出生前検査の世界市場規模および予測は？

2.予測期間中、世界の非侵襲的出生前検査市場を形成するCOVID-19の阻害要因と影響は？

3.非侵襲的出生前検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.非侵襲的出生前検査の世界市場における競争戦略は？

5.非侵襲的出生前検査の世界市場における技術動向と規制の枠組みは？

6.非侵襲的出生前検査の世界市場における主要ベンダーの市場シェアは？

7.非侵襲的出生前検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 母親の年齢が上がるにつれて染色体異常の発生率が増加
  - 侵襲的手法よりも非侵襲的手法を好む傾向が高まっている
  - 平均的および低リスク妊娠に対する償還ポリシーの改善
- 抑制要因
  - 熟練した専門家の不足
- 機会
  - NIPTの認知度の向上
  - 中国、インド、ブラジル、メキシコなどの未開発の新興市場
- 課題
  - 特に肥満女性における検査結果の信頼性
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章非侵襲的出生前検査市場：製品別

消耗品
- アッセイキットおよび試薬
- 使い捨て用品
楽器
- マイクロアレイ
- 次世代シーケンスシステム
- ポリメラーゼ連鎖反応装置
- 超音波装置

第7章非侵襲的出生前検査市場：方法別

生化学的スクリーニング検査
母体血漿検査における無細胞 DNA
母体の血液検査における胎児細胞
超音波検出

第8章非侵襲的出生前検査市場：用途別

微小欠失症候群
トリソミー

第9章非侵襲的出生前検査市場：エンドユーザー別

診断研究所
病院

第10章南北アメリカの非侵襲的出生前検査市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋地域の非侵襲的出生前検査市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカの非侵襲的出生前検査市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第14章掲載企業一覧

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 6. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 7. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 8. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. NON-INVASIVE PRENATAL TESTING MARKET DYNAMICS
FIGURE 10. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 6. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 10. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 16. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 47. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 49. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 55. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 79. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 80. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 81. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 87. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 97. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 99. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 133. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 135. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 152. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 154. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 158. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 160. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 166. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 172. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 178. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 188. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 190. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 206. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 208. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 212. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 214. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 218. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 220. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 244. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 262. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 277. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 278. NON-INVASIVE PRENATAL TESTING MARKET LICENSE & PRICING

Product Code: MRR-036C5CF3B522

The Global Non-invasive Prenatal Testing Market is forecasted to grow significantly, with a projected USD 6,489.03 million in 2023 at a CAGR of 13.79% and expected to reach a staggering USD 16,054.39 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Non-invasive Prenatal Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Non-invasive Prenatal Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits & Reagents and Disposables. The Instruments is further studied across Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, and Ultrasound Devices. The Consumables is projected to witness significant market share during forecast period.

Based on Method, market is studied across Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests, and Ultrasound Detection. The Cell-free DNA in Maternal Plasma Tests is projected to witness significant market share during forecast period.

Based on Application, market is studied across Microdeletion Syndrome and Trisomy. The Microdeletion Syndrome is projected to witness significant market share during forecast period.

Based on End User, market is studied across Diagnostic Laboratories and Hospitals. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Non-invasive Prenatal Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Non-invasive Prenatal Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Non-invasive Prenatal Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-invasive Prenatal Testing Market?

4. What is the competitive strategic window for opportunities in the Global Non-invasive Prenatal Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Non-invasive Prenatal Testing Market?

6. What is the market share of the leading vendors in the Global Non-invasive Prenatal Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Non-invasive Prenatal Testing Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Non-invasive Prenatal Testing Market, by Product, 2022 vs 2030
4.3. Non-invasive Prenatal Testing Market, by Method, 2022 vs 2030
4.4. Non-invasive Prenatal Testing Market, by Application, 2022 vs 2030
4.5. Non-invasive Prenatal Testing Market, by End User, 2022 vs 2030
4.6. Non-invasive Prenatal Testing Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
  - 5.1.1.2. Growing preference for non-invasive techniques over invasive methods
  - 5.1.1.3. Improving reimbursement policies for average and low-risk pregnancies
- 5.1.2. Restraints
  - 5.1.2.1. Dearth of skilled professionals
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing awareness of NIPT
  - 5.1.3.2. Untapped emerging markets such as China, India, Brazil, and Mexico
- 5.1.4. Challenges
  - 5.1.4.1. Reliability of test results, especially in obese women
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Non-invasive Prenatal Testing Market, by Product

6.1. Introduction
6.2. Consumables
- 6.2.1. Assay Kits & Reagents
- 6.2.2. Disposables
6.3. Instruments
- 6.3.1. Microarrays
- 6.3.2. Next-Generation Sequencing Systems
- 6.3.3. Polymerase Chain Reaction Instruments
- 6.3.4. Ultrasound Devices

7. Non-invasive Prenatal Testing Market, by Method

7.1. Introduction
7.2. Biochemical Screening Tests
7.3. Cell-free DNA in Maternal Plasma Tests
7.4. Fetal Cells in Maternal Blood Tests
7.5. Ultrasound Detection

8. Non-invasive Prenatal Testing Market, by Application

8.1. Introduction
8.2. Microdeletion Syndrome
8.3. Trisomy

9. Non-invasive Prenatal Testing Market, by End User

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals

10. Americas Non-invasive Prenatal Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Non-invasive Prenatal Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Non-invasive Prenatal Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

非侵襲的出生前検査市場：製品、方法、用途、エンドユーザー別-2023-2030年の世界予測

Non-invasive Prenatal Testing Market by Product, Method, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 非侵襲的出生前検査市場：製品別

第7章 非侵襲的出生前検査市場：方法別

第8章 非侵襲的出生前検査市場：用途別

第9章 非侵襲的出生前検査市場：エンドユーザー別

第10章 南北アメリカの非侵襲的出生前検査市場

第11章 アジア太平洋地域の非侵襲的出生前検査市場

第12章 欧州・中東・アフリカの非侵襲的出生前検査市場

第13章 競合情勢

第14章 掲載企業一覧

第15章 付録